1Park KD,Mun KC,Chang EJ,Park SB,Kim HC.Inhibition of erythropoietin activity by cyanate[J].Scand J Urol Nephrol,2004,38(1):69-72.
2Balion CM,Draisey TF,Thibert RJ.Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients[J].Kidney Int,1998,53:488-95.
3Leist M,Ghezzi P,Grasso G,et al.Derivatives of Erythropoietin that are tissue protective but not erythropoietic[J].Science,2004,305(5681):239-42.
4Campana WM,Misasi R,O'Brien JS.Identification of a neurotrophic sequence in erythropoietin[J].Int J Mol Med,1998,1(1):235-41.
5Bernaudin M,Marti HH,Roussel S,et al.A potential role for erythropoietin in focal permanent cerebral ischemia in mice[J].J Cereb Blood Flow Metab,1999,19(6):643-51.
6Siren AL,Knerlich F,Poser W,et al.Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain[J].Acta Neuropathol(Berl),2001,101(3):271-6.
7Brines M,Grasso G,Fiordaliso F,et al.Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor[J].Proc Natl Acad Sci U S A,2004,101(14):14907-12.
8Moon C,Krawczyk M,Paik D,Coleman T,Brines M,et al.Erythropoietin,Modified to Not Stimulate Red Blood Cell Production,Retains Its Cardioprotective Properties[J].J Pharmacol Exp Ther,2006,316(3):999-1005.
9Coleman TR,Westenfelder C,Togel FE,Yang Y,Hu Z,et al.Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities[J].Proc Natl Acad Sci U S A,2006,103(15):5965-70.
10Villa P,van Beek J,Larsen AK,Gerwien J,Christensen S,et al.Reduced functional deficits,neuroinflammation,and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives[J].J Cereb Blood Flow Metab,2006,12.
3Brines M, Cerami A. Discovering erythropoietin's extra -hematopoietic functions: Biology and clinical promise [ J ]. Kidney Int, 2006,70 ( 2 ) : 246 - 250.
4Huang Y, Rabb H, Womer KL. Ischemia - reperfusion and immediate T cell responses [ J ]. Cell Immunol,2007,248 ( 1 ) :4 - 11.
5Spandou E, Tsouchnikas I, Karkavelas G, et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model[ J]. Nephrol Dial Transplant,2006,21 (2) :330 - 336.
6Liu X, Shen J, Jin Y, et al. Recombinant human erythropoietin (rh EPO) preconditioning on nuclear factor - kappa B ( NF - κB) activation & proinflammatory cytokines induced by myocardial ischaemia - reperfusion[ J]. Indian J Med Res ,2006,124( 3 ) :343 - 354.
